Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

INO

Inovio Pharmaceuticals (INO)

Inovio Pharmaceuticals Inc New
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:INO
DateTimeSourceHeadlineSymbolCompany
08/09/20234:23PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INOInovio Pharmaceuticals Inc New
08/09/20234:05PMPR Newswire (US)INOVIO Announces Second Quarter 2023 Financial Results and Provides Strategic UpdateNASDAQ:INOInovio Pharmaceuticals Inc New
08/09/20234:00PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INOInovio Pharmaceuticals Inc New
08/04/20238:00AMPR Newswire (US)INOVIO Reports Inducement Grants Under Inducement PlanNASDAQ:INOInovio Pharmaceuticals Inc New
07/31/20239:43PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INOInovio Pharmaceuticals Inc New
07/26/20239:32AMPR Newswire (US)INOVIO to Report Second Quarter 2023 Financial Results on August 9, 2023NASDAQ:INOInovio Pharmaceuticals Inc New
07/07/20234:35PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:INOInovio Pharmaceuticals Inc New
07/03/20235:12PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INOInovio Pharmaceuticals Inc New
06/23/20234:25PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INOInovio Pharmaceuticals Inc New
06/23/20234:10PMGlobeNewswire Inc.INOVIO Announces Notice of Pendency and Proposed Settlement of Stockholder Derivative ActionsNASDAQ:INOInovio Pharmaceuticals Inc New
06/05/20234:14PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INOInovio Pharmaceuticals Inc New
06/05/20233:57PMEdgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:INOInovio Pharmaceuticals Inc New
06/01/20238:00AMPR Newswire (US)INOVIO Reports Inducement Grants Under Inducement PlanNASDAQ:INOInovio Pharmaceuticals Inc New
05/25/20238:00AMPR Newswire (US)INOVIO to Present at the 2023 Jefferies Healthcare ConferenceNASDAQ:INOInovio Pharmaceuticals Inc New
05/23/20234:13PMPR Newswire (US)INOVIO Announces Orphan Drug Designation for INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis from the European CommissionNASDAQ:INOInovio Pharmaceuticals Inc New
05/18/20234:58PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:INOInovio Pharmaceuticals Inc New
05/18/20234:40PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:INOInovio Pharmaceuticals Inc New
05/17/20234:13PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INOInovio Pharmaceuticals Inc New
05/17/20234:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INOInovio Pharmaceuticals Inc New
05/17/20234:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INOInovio Pharmaceuticals Inc New
05/16/20234:58PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INOInovio Pharmaceuticals Inc New
05/16/20234:56PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INOInovio Pharmaceuticals Inc New
05/16/20234:55PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INOInovio Pharmaceuticals Inc New
05/16/20234:53PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INOInovio Pharmaceuticals Inc New
05/16/20234:49PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INOInovio Pharmaceuticals Inc New
05/12/20234:13PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INOInovio Pharmaceuticals Inc New
05/10/20234:05PMPR Newswire (US)INOVIO Reports First Quarter 2023 Financial Results and Operational HighlightsNASDAQ:INOInovio Pharmaceuticals Inc New
05/10/20234:03PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:INOInovio Pharmaceuticals Inc New
05/08/20238:00AMPR Newswire (US)New Data from Phase 1/2 Trial of INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis Presented at ABEA during COSM 2023NASDAQ:INOInovio Pharmaceuticals Inc New
05/05/20238:00AMPR Newswire (US)INOVIO to Present at the 2023 RBC Capital Markets Global Healthcare ConferenceNASDAQ:INOInovio Pharmaceuticals Inc New
 Showing the most relevant articles for your search:NASDAQ:INO